Repadax M 2mg/500mg Tablet SR
Marketer
Daxia Healthcare
Salt Composition
Repaglinide (2mg) + Metformin (500mg)
Overview Repadax M 2mg/500mg Tablet SR
Diabex Duo 2mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels, as abrupt cessation can lead to hyperglycemia, increasing the risk of renal impairment, vision loss, neuropathy, and limb complications. This medication forms part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are essential for effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, lightheadedness, headaches, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are vital. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Primary Ingredients of Repadax M 2mg/500mg Tablet SR
No text provided to rephrase.
Uses of Repadax M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Repadax M 2mg/500mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Repadax M 2mg/500mg sustained-release tablets with food.
Common Side effects of Repadax M 2mg/500mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Sweating
- Dizziness
- Diarrhea
- Loss of appetite
- Nausea
- Stomach pain
- Taste change
- Weight gain
How to use Repadax M 2mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Repadax M 2mg/500mg Extended-Release Tablets should be administered with a meal.
How Repadax M 2mg/500mg Tablet SR works:
Repadax M, a sustained-release tablet containing 2mg/500mg of a dual antidiabetic formulation, combines two distinct medications.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Repadax M 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Repadax M 2mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The extended-release Repadax M 2mg/500mg tablet is likely safe for breastfeeding mothers. Available human data indicates minimal infant risk from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Repadax M 2mg/500mg SR tablets, as dose modification may be necessary. Consult your physician for guidance. Repadax M 2mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
For individuals with liver impairment, Repadax M 2mg/500mg SR tablets require careful administration. Dosage modification of Repadax M 2mg/500mg SR tablets may be necessary. Physician consultation is advised. In patients experiencing mild to moderate liver disease, Repadax M 2mg/500mg SR tablets are typically initiated at a low dosage; however, their use is contraindicated in those with severe liver dysfunction.
What if you forget to take Repadax M 2mg/500mg Tablet SR :
NA
Facts to Know About Repadax M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently